| Q38033344 | A systematic review of screening tools for predicting the development of dementia |
| Q64045770 | Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability |
| Q51994676 | CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease. |
| Q51025153 | CERAD-neuropsychological battery in screening mild Alzheimer's disease. |
| Q48449830 | Challenges in the clinical diagnosis of Alzheimer's disease: influence of "family coaching" on the mini-mental state examination. |
| Q50782411 | Diagnostic accuracy of a new instrument for detecting cognitive dysfunction. |
| Q35043616 | Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease |
| Q36607252 | Ethical issues associated with the assessment of exaggeration, poor effort, and malingering |
| Q21559700 | Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patients |
| Q34175651 | Factors associated with primary care physicians' recognition of cognitive impairment in their older patients |
| Q47288880 | Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease |
| Q51903964 | Interviewing cognitively impaired older adults: how useful is a cognitive interview? |
| Q40185953 | Memory performance and mild cognitive impairment in Black and White community elders. |
| Q35172333 | Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment |
| Q24186302 | Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations |
| Q28469059 | Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001 |
| Q22242620 | Multiple cognitive deficits during the transition to Alzheimer's disease |
| Q51985721 | Neurocognitive testing supports a broader concept of mild cognitive impairment. |
| Q73208413 | Oestradiol concentrations in prediction of cognitive decline in women |
| Q47619052 | Predicting cognitive sequelae in survivors of critical illness with cognitive screening tests |
| Q39658978 | Predictors of future cognitive decline in persons with mild cognitive impairment |
| Q63208301 | Prognosis of Early-Onset vs. Late-Onset Mild Cognitive Impairment: Comparison of Conversion Rates and Its Predictors |
| Q51973983 | Risk factors and early signs of Alzheimer's disease in a family study sample. Risk of AD. |
| Q38403541 | Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population. |
| Q40470597 | Selective memory impairment on an adapted Mini-Mental State Examination increases risk of future dementia. |
| Q46557491 | Smell test predicts performance on delayed recall memory test in elderly with depression |
| Q38381554 | The California Verbal Learning Test and other standard clinical neuropsychological tests to predict conversion from mild memory impairment to dementia |
| Q41901117 | The Memory Alteration Test Discriminates between Cognitively Healthy Status, Mild Cognitive Impairment and Alzheimer's Disease |
| Q37267578 | The Memory and Aging Telephone Screen: development and preliminary validation |
| Q33334232 | The accuracy of the MMSE in detecting cognitive impairment when administered by general practitioners: a prospective observational study |
| Q47673724 | The association between educational parameters and a cognitive screening measure in older blacks |
| Q40576354 | The health status of community based elderly in the United Arab Emirates. |
| Q38427184 | Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment |